A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis

Ivan R. Schwab, Mitchell Friedlaender, James P McCulley, Steven J. Lichtenstein, C. Thomas Moran, Mark Abelson, Gavin Bahadur, Richard Braunstein, Robert Caine, Timothy Cavanaugh, Steven Dell, Peter Donshik, Norman Levy, Bernard Milstein, Thomas Mundorf, Terrence O'Brien, Steven Prepas, Robert Reidy, Kenneth Sall, Alan SugarShailaja Valluri, Francis Wapner, Thomas Wolf

Ophthalmology
Ophthalmology

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Sort by
Weight
Alphabetically

A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis

Fingerprint

Medicine & Life Sciences